Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
49,129
Value
$831.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of NTLA by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202649,129$831.3K<0.1%+37,931+338.7%AddedHolders
Q1 202611,198$143.6K<0.1%+11,198NewHolders
Q4 20250$00.0%−36,986−100.0%Sold outHolders
Q3 202536,986$638.7K<0.1%+20,367+122.6%AddedHolders
Q2 202516,619$155.9K<0.1%−302−1.8%ReducedHolders
Q1 202516,921$120.3K<0.1%+1,282+8.2%AddedHolders
Q4 202415,639$182.3K<0.1%−4,639−22.9%ReducedHolders
Q3 202420,278$415.0K<0.1%−2,967−12.8%ReducedHolders
Q2 202423,245$515.0K<0.1%−113−0.5%ReducedHolders
Q1 202423,358$642.0K<0.1%−439−1.8%ReducedHolders
Q4 202323,797$724.0K<0.1%−1,782−7.0%ReducedHolders
Q3 202325,579$808.0K<0.1%−2,360−8.4%ReducedHolders
Q2 202327,939$1.14M<0.1%−427−1.5%ReducedHolders
Q1 202328,366$1.06M<0.1%+2,279+8.7%AddedHolders
Q4 202226,087$910.0K<0.1%−1,708−6.1%ReducedHolders
Q3 202227,795$1.55M<0.1%+112+0.4%AddedHolders
Q2 202227,683$1.44M<0.1%−5,429−16.4%ReducedHolders
Q1 202233,112$2.41M<0.1%−3,945−10.6%ReducedHolders
Q4 202137,057$4.38M<0.1%+4,873+15.1%AddedHolders
Q3 202132,184$4.32M<0.1%+3,660+12.8%AddedHolders
Q2 202128,524$4.62M<0.1%−6,332−18.2%ReducedHolders
Q1 202134,856$2.80M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.